Robert Vassallo

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Diffuse lung diseases in cigarette smokers
    Robert Vassallo
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Semin Respir Crit Care Med 33:533-42. 2012
  2. ncbi request reprint Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care, and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    N Engl J Med 346:484-90. 2002
  3. ncbi request reprint Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Immunol 175:2684-91. 2005
  4. pmc Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses
    Robert Vassallo
    Thoracic Diseases Research Unit, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Mol Immunol 45:3321-9. 2008
  5. ncbi request reprint Selective suppression of dendritic cell functions by cigarette smoke extract
    Robert Vassallo
    Mayo Clinic, Rochester, MN 55905, USA
    Chest 125:107S. 2004
  6. ncbi request reprint Advances in the treatment of rheumatic interstitial lung disease
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Department of Internal Medicine, Mayo Clinic and Foundation, Stabile Building 8 54, 200 First Street SW, Rochester, MN 55905, USA
    Curr Opin Rheumatol 16:186-91. 2004
  7. pmc Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study
    Robert Vassallo
    The Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Department of Internal Medicine, the Clinical Immunology and Immunotherapeutics Program, Mayo Clinic and Foundation, Rochester, Minnesota, 55905, USA
    Respir Res 11:45. 2010
  8. ncbi request reprint The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Chest 124:1199-205. 2003
  9. ncbi request reprint Viral-induced inflammation in interstitial lung diseases
    Robert Vassallo
    Thoracic Diseases Research Unit, Mayo Clinic, Rochester, MN 55905, USA
    Semin Respir Infect 18:55-60. 2003
  10. ncbi request reprint Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism
    Eva M Carmona
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    J Immunol 177:459-67. 2006

Collaborators

Detail Information

Publications35

  1. ncbi request reprint Diffuse lung diseases in cigarette smokers
    Robert Vassallo
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Semin Respir Crit Care Med 33:533-42. 2012
    ..Understanding mechanisms by which tobacco induces diffuse lung pathology is critical in the pursuit of novel therapeutic approaches for these diseases...
  2. ncbi request reprint Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care, and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    N Engl J Med 346:484-90. 2002
    ..Pulmonary Langerhans'-cell histiocytosis is an uncommon interstitial lung disease in adults. It has an unpredictable course and may be associated with an increased susceptibility to the development of malignant neoplasms...
  3. ncbi request reprint Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Immunol 175:2684-91. 2005
    ..These data provide evidence that soluble components extracted from cigarette smoke suppress key DC functions and favor the development of Th-2 immunity...
  4. pmc Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses
    Robert Vassallo
    Thoracic Diseases Research Unit, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Mol Immunol 45:3321-9. 2008
    ..Certain pharmacologic strategies such as anti-oxidant therapy may be only partially effective in mitigating cigarette smoke-induced pro-inflammatory DC-mediated responses in smokers...
  5. ncbi request reprint Selective suppression of dendritic cell functions by cigarette smoke extract
    Robert Vassallo
    Mayo Clinic, Rochester, MN 55905, USA
    Chest 125:107S. 2004
  6. ncbi request reprint Advances in the treatment of rheumatic interstitial lung disease
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Department of Internal Medicine, Mayo Clinic and Foundation, Stabile Building 8 54, 200 First Street SW, Rochester, MN 55905, USA
    Curr Opin Rheumatol 16:186-91. 2004
    ..Interstitial lung disease frequently complicates the rheumatic diseases. The purpose of this review is to outline recent advances and current concepts regarding the management of these interstitial lung diseases...
  7. pmc Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study
    Robert Vassallo
    The Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Department of Internal Medicine, the Clinical Immunology and Immunotherapeutics Program, Mayo Clinic and Foundation, Rochester, Minnesota, 55905, USA
    Respir Res 11:45. 2010
    ..Although evident that cigarette smoke, the primary cause of COPD, significantly influences dendritic cell functions, little is known about the roles of dendritic cells in the pathogenesis of COPD...
  8. ncbi request reprint The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    Chest 124:1199-205. 2003
    ....
  9. ncbi request reprint Viral-induced inflammation in interstitial lung diseases
    Robert Vassallo
    Thoracic Diseases Research Unit, Mayo Clinic, Rochester, MN 55905, USA
    Semin Respir Infect 18:55-60. 2003
    ....
  10. ncbi request reprint Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism
    Eva M Carmona
    Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    J Immunol 177:459-67. 2006
    ..This suggests that dysregulation of FasL could further enhance exuberant and prolonged cytokine production by DCs following DC-T cell interactions, further promoting lung inflammation typical of Pneumocystis pneumonia...
  11. pmc Brain-derived neurotrophic factor in cigarette smoke-induced airway hyperreactivity
    Venkatachalem Sathish
    Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA
    Am J Respir Cell Mol Biol 48:431-8. 2013
    ..These data suggest that cigarette smoke is a potent inducer of BDNF and TrkB expression and signaling in ASM, which then contribute to cigarette smoke-induced airway hyperresponsiveness...
  12. doi request reprint Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study
    Tim Bongartz
    Rheumatology Department, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Arthritis Rheum 62:1583-91. 2010
    ..Interstitial lung disease (ILD) has been recognized as an important comorbidity in rheumatoid arthritis (RA). We undertook the current study to assess incidence, predictors, and mortality of RA-associated ILD...
  13. pmc Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways
    Paula R Kroening
    Department of Internal Medicine, Thoracic Diseases Research Unit, Division of Pulmonary Critical Care, Mayo Clinic and Foundation, Rochester, MN 55905, USA
    J Immunol 181:1536-47. 2008
    ..Some of the cigarette smoke-induced inhibitory effects on DC function may be mitigated by antioxidants...
  14. doi request reprint Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study
    Carlotta Nannini
    Mayo Clinic College of Medicine, Rochester, Minnesota
    Arthritis Care Res (Hoboken) 65:1243-50. 2013
    ..We therefore aimed to assess the incidence, risk factors, and mortality of OLD in patients with RA...
  15. ncbi request reprint Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease
    Jay H Ryu
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Chest 127:178-84. 2005
    ..Desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) are uncommon forms of interstitial lung disease and have been incompletely characterized...
  16. doi request reprint Tobacco smoke-related diffuse lung diseases
    Robert Vassallo
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Semin Respir Crit Care Med 29:643-50. 2008
    ....
  17. doi request reprint Smoking-related interstitial lung diseases
    Robert Vassallo
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Clin Chest Med 33:165-78. 2012
    ..The role of pharmacotherapy with corticosteroids or other immunomodulating agents is not well established but may be considered in patients with progressive forms of smoking-related interstitial lung diseases...
  18. ncbi request reprint Pulmonary Langerhans' cell histiocytosis
    Robert Vassallo
    Division of Pulmonary and Critical Care and Internal Medicine, Mayo Clinic and Foundation, 200 First Street Southwest, Rochester, MN, 55905, USA
    Clin Chest Med 25:561-71, vii. 2004
    ..This article summarizes recent advances and current understanding of PLCH...
  19. ncbi request reprint Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
    Nithima Chaowalit
    Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:1269-75. 2004
    ..To determine the echocardiographic characteristics and impact on survival of pulmonary hypertension (PH) and correlations between echocardiographic and clinical variables in patients with pulmonary Langerhans cell histiocytosis (PLCH)...
  20. ncbi request reprint Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker
    Michelle R Aerni
    Department of Pulmonary and Critical Care Medicine and Thoracic Diseases Research Unit, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Respir Med 102:316-9. 2008
    ..We propose that, in selected cases, 2-CdA should be considered in the management of pulmonary LCH...
  21. ncbi request reprint Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis
    Carl Turesson
    Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Arthritis Rheum 52:73-9. 2005
    ..To study lymphocyte markers in rheumatoid arthritis (RA)-associated interstitial pneumonitis (IP) compared with idiopathic IP...
  22. pmc Pulmonary langerhans cell histiocytosis
    Harpreet S Suri
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
    Orphanet J Rare Dis 7:16. 2012
    ..Complications like pneumothoraces and secondary pulmonary hypertension may shorten life expectancy. Patients with progressive disease may require lung transplantation...
  23. ncbi request reprint Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients
    Michelle R Aerni
    Division of Pulmonary and Critical Care Medicine, Desk East 18, Mayo Clinic, 200 1st St SW, Rochester, MN, USA
    Respir Med 102:307-12. 2008
    ..Follicular bronchiolitis is a histopathologic finding that occurs in diverse clinical contexts. The current study was conducted to characterize clinico-radiologic features, and assess outcomes associated with follicular bronchiolitis...
  24. ncbi request reprint Pneumothorax in pulmonary Langerhans cell histiocytosis
    Jose L Mendez
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Chest 125:1028-32. 2004
    ..Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease characterized by development of cystic changes that predispose to occurrence of pneumothorax...
  25. ncbi request reprint Diffuse bronchiolar disease due to chronic occult aspiration
    Terrance W Barnes
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 81:172-6. 2006
    ..To describe clinical, radiological, and histopathologic features of diffuse bronchiolar disease due to chronic occult aspiration...
  26. doi request reprint Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis
    Bryan J Krajicek
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Chest 135:1542-9. 2009
    ..Although the chest CT scan characteristics of PLCH are well recognized, the PET scan characteristics of adults with PLCH are unknown...
  27. ncbi request reprint Cigarette smoking and diffuse lung disease
    Rajesh R Patel
    Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Drugs 68:1511-27. 2008
    ....
  28. pmc Asthma-related environmental fungus, Alternaria, activates dendritic cells and produces potent Th2 adjuvant activity
    Takao Kobayashi
    Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 182:2502-10. 2009
    ..Such immunogenic properties of certain environmental fungi may explain their strong relationships with human asthma and allergic diseases...
  29. pmc Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle
    Dan F Smelter
    Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA
    J Immunol 185:3035-40. 2010
    ..Overall, these novel data suggest that cigarette smoke, TSLP, and ASM are functionally linked and that cigarette smoke-induced increase in airway contractility may be mediated via ASM-derived increases in TSLP signaling...
  30. doi request reprint Intrathoracic manifestations of Rosai-Dorfman disease
    Rodrigo Cartin-Ceba
    Mayo Clinic, 200, Rochester, MN 55905, USA
    Respir Med 104:1344-9. 2010
    ..Although cutaneous and lymph node involvement are relatively well-described, intrathoracic manifestations of RDD have only occasionally been reported...
  31. doi request reprint Lack of FDG uptake in small cell carcinoma associated with ANNA-1 positive paraneoplastic autonomic neuropathy
    Matthew S Block
    Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    J Thorac Oncol 3:542-4. 2008
    ....
  32. ncbi request reprint Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation
    Frances Lebron
    Department of Immunology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    J Biol Chem 278:25001-8. 2003
    ..carinii beta-glucan. These data demonstrate that P. carinii beta-glucan acts as potent inducer of macrophage activation through NF-kappaB utilizing cellular receptors and signaling pathways distinct from LPS...
  33. ncbi request reprint Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition
    Robert Vassallo
    Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
    Chest 122:1093-6. 2002
    ..This report suggests that inhibition of TNF-alpha may be of significant benefit to patients with fibrosing lung conditions in the setting of RA...
  34. pmc Chronic obstructive pulmonary disease after myocardial infarction in the community
    Francesca Bursi
    Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am Heart J 160:95-101. 2010
    ..We examined, in a geographically defined community, the prevalence of COPD in patients with MI, its impact on mortality, and how these associations changed over time...
  35. doi request reprint A 40-year-old man with hemolytic anemia, Ig deficiency, and bilateral pulmonary infiltrates
    Elisabetta Balestro
    Respiratory Disease Department, Hospital S Bassiano, Bassano del Grappa, Italy
    Chest 133:1517-23. 2008